EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

[177Lu]Lu-PSMA radioligand therapy in younger prostate cancer patients: A matched-pair analysis between patients ≤ 65 and ≥ 70 years old

Johannes Hornfeck, Paul J Dahlmann, Sophie C Siegmund, Franz J Gildehaus, Astrid Delker, Nina-Sophie Schmidt-Hegemann, Ralph A Bundschuh, Mathias J Zacherl, Konrad Klimek, Jozefina Casuscelli, Christian G Stief, Rudolf A Werner und 1 weitere

European Journal of Nuclear Medicine and Molecular Imaging · 2026-07 · 53 (8) · 4873-4882

DOI: 10.1007/s00259-026-07817-2 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 02.03.2026. Verfasst von Johannes Hornfeck und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Lutetium, Radioisotopes, Glutamate Carboxypeptidase II. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Klinikum der Universität München.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsLutetiumRadioisotopesGlutamate Carboxypeptidase IIAntigens, SurfaceDipeptidesHumansMaleAgedMiddle AgedLigandsProstate-Specific AntigenTreatment Outcome

Stichwörter der Autor:innen

Age-related outcomePSMAProstate carcinomaRadioligand therapy

Substanzen

LutetiumRadioisotopesLutetium-177Ligandslutetium (177Lu) vipivotide tetraxetanGlutamate Carboxypeptidase IIAntigens, SurfaceProstate-Specific AntigenFOLH1 protein, humanDipeptides

Autor:innen und Institutionen

  • Department of Nuclear Medicine, LMU University Hospital, LMU Munich, Munich, Germany.
  • Bavarian Cancer Research Center (BZKF), partner site Munich, Munich, Germany.
  • Department of Radiation Oncology, LMU University Hospital, LMU Munich, Munich, Germany.
  • Department of Nuclear Medicine, University Hospital Carl Gustav Carus Dresden, Dresden, Germany.
  • Institute of Radiopharmaceutical Cancer Research, Helmholtz Zentrum Dresden-Rossendorf (HZDR), Rossendorf, Germany.
  • German Cancer Consortium (DKTK), Partner Site Dresden, Dresden, Germany.

ORCID-Profile: Liam Widjaja

Förderung

  • Klinikum der Universität München

Zitieren

APA

Hornfeck, J., Dahlmann, P. J., Siegmund, S. C., Gildehaus, F. J., Delker, A., Schmidt-Hegemann, N. S., Bundschuh, R. A., Zacherl, M. J., Klimek, K., Casuscelli, J., Stief, C. G., Werner, R. A., & Widjaja, L. (2026). [177Lu]Lu-PSMA radioligand therapy in younger prostate cancer patients: A matched-pair analysis between patients ≤ 65 and ≥ 70 years old. European Journal of Nuclear Medicine and Molecular Imaging, 53(8), 4873-4882. https://doi.org/10.1007/s00259-026-07817-2

Vancouver

Hornfeck J, Dahlmann PJ, Siegmund SC, Gildehaus FJ, Delker A, Schmidt-Hegemann NS, et al. [177Lu]Lu-PSMA radioligand therapy in younger prostate cancer patients: A matched-pair analysis between patients ≤ 65 and ≥ 70 years old. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(8):4873-4882. doi:10.1007/s00259-026-07817-2

BibTeX
@article{Hornfeck2026,
  author = {Hornfeck, Johannes and Dahlmann, Paul J and Siegmund, Sophie C and Gildehaus, Franz J and Delker, Astrid and Schmidt-Hegemann, Nina-Sophie and Bundschuh, Ralph A and Zacherl, Mathias J and Klimek, Konrad and Casuscelli, Jozefina and Stief, Christian G and Werner, Rudolf A and Widjaja, Liam},
  title = {[177Lu]Lu-PSMA radioligand therapy in younger prostate cancer patients: A matched-pair analysis between patients ≤ 65 and ≥ 70 years old},
  journal = {European Journal of Nuclear Medicine and Molecular Imaging},
  year = {2026},
  volume = {53},
  number = {8},
  pages = {4873--4882},
  doi = {10.1007/s00259-026-07817-2}
}
Kostenlos starten →